Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...

The government of Japan has approved a draft revision of a law aimed at strengthening the development of new drugs in the ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Delivering drugs to specific, hard-to-reach areas in the human body remains a challenge in drug development. Typically, drug molecules administered via pills or injections circulate randomly through ...

When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA-1.57%decrease; red down pointing triangle, its scientists thought they had a future lung medicine in their ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.